26-A-17995-ACC CLINICAL OUTCOMES OF SGLT2 INHIBITOR USE IN HEART FAILURE WITH END-STAGE RENAL DISEASE: A PROPENSITY-MATCHED TRINETX ANALYSISRicardo Estrada Mendizabal, Rosy Thachil, Mohamed Bassiony et al.|Journal of the American College of Cardiology|2026Cited by 0